DUBLIN--(BUSINESS WIRE)--Aug 30, 2018--The "Global Insulin Pumps Industry (China-specific Market Assessment) - Drivers, Restraints, Opportunities, Trends, and Forecasts: 2018-2024" report has been added to ResearchAndMarkets.com's offering.

The global insulin pumps market is estimated to witness a CAGR of 9.7% during the forecast period 2018-2024. Increased prevalence of diabetes, growing popularity of advanced insulin pumps, and the introduction of new technologies are driving the market growth.

North America is set to be the leading region for the insulin pumps market growth followed by Europe. Asia Pacific and ROW are set to be the emerging regions. The emerging markets have a high potential to grow owing to an increase in patient population and focus toward healthcare infrastructure.

The insulin pumps market has the lowest penetration in emerging regions, and most of the vendors are targeting India, Thailand, Indonesia, and Vietnam. These countries are the major revenue contributors in the APAC region. A higher incidence of obesity will fuel the market expansion, which will result in the high prevalence of diabetes.

Tethered insulin pump is dominating with more than 70% of the market share. Increasing aging population, rise in prevalence of diabetes, need for early prevention of diseases, and growing awareness about a healthy lifestyle are expected to drive the market growth.

The insulin pumps market is highly fragmented and has immense growth opportunities for vendors, especially in developing regions. The market has the presence of many global, regional, and local players with strong competition among each other.

Market Dynamics

Drivers

Huge Surge in Aging Population Increase in Awareness Increasing Number of Diabetic Patients Rising Incidences of Government Initiatives

Opportunities

Technological Advances in Insulin Pump Insulin Pumps Replacing Traditional Methods Increasing Partnership and Collaboration Activities Focus on Early Diabetes Management Rapid Growth in Emerging Countries

Restraints

High Price of Latest Insulin Pumps Unfavorable Reimbursement Plans Availability of Substitutes Competition Among Major Vendors

Companies Featured

F. Hoffmann-La Roche (Roche) Ltd. Insulet Corp. Medtronic plc MicroPort Scientific Corp. Tandem Diabetes Care Eli Lilly and Company Animas Corp. Sooil Development Co. Ltd. Ypsomed Holding AG Valeritas Inc. GlySens ICGM

For more information about this report visit https://www.researchandmarkets.com/research/lqbtzb/global_insulin?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180830005317/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Diabetes Devices ,Infusions and Injectables ,Endocrine and Metabolic Disorders Drugs

KEYWORD: ASIA PACIFIC

INDUSTRY KEYWORD: HEALTH MEDICAL DEVICES DIABETES

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 08/30/2018 05:29 AM/DISC: 08/30/2018 05:29 AM

http://www.businesswire.com/news/home/20180830005317/en